Episode
Episode 53. Belantamab Makes a Comeback with Dr. Hang Quach
- Podcast
- Blood Cancer Talks
- Published
- Nov 13, 2024
- Duration seconds
- 2681
- Processing state
not_requested- Canonical source
- https://share.transistor.fm/s/5d7e0d35
Actions
POST https://stenobird.com/v1/public/podcasts/blood-cancer-talks-5570002/episodes/episode-53-belantamab-makes-a-comeback-with-dr-hang-quach/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/blood-cancer-talks-5570002/episode-53-belantamab-makes-a-comeback-with-dr-hang-quach.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode, we discuss the comeback of belantamab mafadotin in multiple myeloma with Dr. Hang Quach, along with some other important abstracts presented at EHA/ASCO 2024. Here are the studies we discussed: 1. DREAMM-7 RCT: Belantamab-Vd vs Daratumumab-Vd in relapsed MM. https://pubmed.ncbi.nlm.nih.gov/38828933/ 2. DREAMM-8 RCT: Belantamab-Pd vs PVd in relapsed MM. https://pubmed.ncbi.nlm.nih.gov/38828951/ 3. Long-term follow-up of CASSIOPEIA Trial: https://pubmed.ncbi.nlm.nih.gov/38889735/ 4. Update on MRD data from PERSEUS Trial: https://ascopubs.org/doi/10.1200/JCO.2024.42.16_suppl.7502